VAX-seq: the future of mRNA vaccine analysis and quality assurance?

Researchers proposed a simplified approach for analyzing mRNA vaccines using long-read sequencing.

Updated: FDA approves Sarepta’s Duchenne muscular dystrophy gene therapy via accelerated pathway

The FDA granted accelerated approval to Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy for boys aged 4 and 5 in a decision that allows access

June 23, 2023

PhenomeX announces the release of SpotLight™ Human Lambda reagent for the Beacon® platform to accelerate cell line development workflows

PhenomeX Inc., a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human Lambda reagent for the Beacon®

September 25, 2023

WHO to convene panel to determine whether mpox outbreak is a public health emergency

The director general of the World Health Organization announced Wednesday that he will convene a panel of experts to advise him on whether the expanding

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.